Drug Profile
Research programme: bone allografting therapy - AskBio
Alternative Names: Biological AllograftLatest Information Update: 27 May 2021
Price :
$50
*
At a glance
- Originator Asklepios BioPharmaceutical
- Class
- Mechanism of Action Tissue replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Bone disorders
Most Recent Events
- 26 Sep 2012 No development reported - Preclinical for Bone disorders in USA (Parenteral)
- 12 Sep 2005 Preclinical trials in Bone disorders in USA (unspecified route)